PMON267 Comparison Between Single Time Point Testing and 24-Hour Average Concentration of Total Testosterone in Hypogonadal Men Treated with an Oral Testosterone Undecanoate Softgel (JATENZO®)

In 2019, a novel, first-in-class testosterone (T) replacement therapy (TRT), oral testosterone undecanoate (TU) was approved by the U.S. FDA for the treatment of male hypogonadism. During clinical trials, dose adjustments were based on 24-hr average T concentration (Cavg) because single T measuremen...

Descripción completa

Detalles Bibliográficos
Autores principales: Swerdloff, Ronald, Wang, Christina, Gittelman, Marc, Newmark, Jay, Woun Seo, B, Rohowsky, Nestor, Dudley, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625434/
http://dx.doi.org/10.1210/jendso/bvac150.1452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625434/
http://dx.doi.org/10.1210/jendso/bvac150.1452

Ejemplares similares